Kolexia
Furst Sabine
Médecine interne
Centre Paoli-Calmettes
Marseille, France
273 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie du greffon contre l'hôte Lymphomes Leucémies Leucémie aigüe myéloïde Tumeurs hématologiques Leucémie myéloïde Maladie de Hodgkin Maladie chronique Maladie aigüe

Industries

Novartis
4 collaboration(s)
Dernière en 2022
Gilead
4 collaboration(s)
Dernière en 2023
MSD
2 collaboration(s)
Dernière en 2023
Vertex
1 collaboration(s)
Dernière en 2023

Dernières activités

Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial.
Blood cancer journal   19 février 2024
A Single Center Real World Experience of Allogeneic HSCT of Patients with MDS/CMML in Aged Population
Abstracts from the 2024 Tandem Meetings of ASTCT and CIBMTR, February 21-24, 2024, San Antonio, Texas, USA   01 février 2024
Cord blood transplantation for adult lymphoid neoplasms in Europe and Japan.
Blood advances   15 décembre 2023
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome.
Bone marrow transplantation   03 novembre 2023
Efficacy and Tolerance of Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia : A Graall Study from the Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study.
British journal of haematology   02 octobre 2023
Oxidation is an underappreciated post-translational modification in the regulation of immune responses associated with changes in phosphorylation.
Frontiers in immunology   22 septembre 2023
POSTER: AML-110 Outcome of Acute Myeloid Leukemia Relapse After Allogenic Stem Cell Transplantation: A Single-Institution Retrospective Study
Proceedings of the Society of Hematologic Oncology 2023 Annual Meeting   01 septembre 2023
AML-110 Outcome of Acute Myeloid Leukemia Relapse After Allogenic Stem Cell Transplantation: A Single-Institution Retrospective Study
Proceedings of the Society of Hematologic Oncology 2023 Annual Meeting   01 septembre 2023
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation.
Bone marrow transplantation   09 août 2023